Literature DB >> 18627243

Model for the deposition of aerosol particles in the respiratory tract of the rat. I. Nonhygroscopic particle deposition.

Otmar Schmid1, Ines Bolle, Volker Harder, Erwin Karg, Shinji Takenaka, Holger Schulz, George A Ferron.   

Abstract

Rats are used to test the toxicological and pharmacological effects of aerosol particles on the organism. For estimates of the delivered aerosol dose, lung deposition models provide a valuable tool. Here a previously developed deposition model for nonhygroscopic and hygroscopic aerosol particles in the lungs of man (Ferron et al., J. Aerosol Sci. 1988, 19:611) is adapted to the rat by implementing a lung structure for the rat combined with empirical equations for particle deposition due to impaction/sedimentation in the extrathoracic region and in bifurcations. To account for the effect of body weight (BW) on the physiological parameters (lung size, respiration frequency) we present BW-scaling laws with an estimated accuracy of about 16%. The present model shows good agreement with the measured total deposition (per breath) and other models from the literature to within the variability of the experimental data (20% absolute). Our calculations show that the variability of the experimental data is consistent with the combined effects from realistic variations in particle properties (mainly density) and physiological parameters (mainly activity level). For the alveolar region, which is of particular significance for pharmacological and health studies, we show that although the activity level may change the deposited dose by up to a factor of 2.2 for particles between 0.05 and 2.0 microm in diameter, the alveolar dose is almost independent (to within 10%) of activity level for particles between 0.5 and 1 microm, which makes this size range advantageous for pharmacological and toxicological experiments. The present model allows estimates of the total and regional particle dose deposited in the lungs of rats, which are consistent with experimental data. The advantage of the present model is that hygroscopic growth can be included in the calculations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627243     DOI: 10.1089/jamp.2008.0689

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  10 in total

1.  Micron-sized intrapulmonary particle deposition in the developing rat lung.

Authors:  Holger Schulz; Gunter Eder; Ines Bolle; Akira Tsuda; Stefan Karrasch
Journal:  J Appl Physiol (1985)       Date:  2011-12-08

2.  Distribution of aerosolized particles in healthy and emphysematous rat lungs: comparison between experimental and numerical studies.

Authors:  Jessica M Oakes; Alison L Marsden; Céline Grandmont; Chantal Darquenne; Irene E Vignon-Clementel
Journal:  J Biomech       Date:  2015-01-22       Impact factor: 2.712

3.  Sampling port for real-time analysis of bioaerosol in whole body exposure system for animal aerosol model development.

Authors:  Divey Saini; Gregory W Hopkins; Ching-Ju Chen; Sarah A Seay; Eva M Click; Sunhee Lee; Justin M Hartings; Richard Frothingham
Journal:  J Pharmacol Toxicol Methods       Date:  2010-09-16       Impact factor: 1.950

4.  Small particles disrupt postnatal airway development.

Authors:  DongYoub Lee; Chris Wallis; Anthony S Wexler; Edward S Schelegle; Laura S Van Winkle; Charles G Plopper; Michelle V Fanucchi; Ben Kumfer; Ian M Kennedy; Jackie K W Chan
Journal:  J Appl Physiol (1985)       Date:  2010-07-15

5.  Breath-by-breath measurement of particle deposition in the lung of spontaneously breathing rats.

Authors:  S Karrasch; G Eder; I Bolle; A Tsuda; H Schulz
Journal:  J Appl Physiol (1985)       Date:  2009-07-30

6.  Systems Pharmacology Approach for Prediction of Pulmonary and Systemic Pharmacokinetics and Receptor Occupancy of Inhaled Drugs.

Authors:  E Boger; N Evans; M Chappell; A Lundqvist; P Ewing; A Wigenborg; M Fridén
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-04-14

7.  Adapting the Aerogen Mesh Nebulizer for Dried Aerosol Exposures Using the PreciseInhale Platform.

Authors:  Per Gerde; Mattias Nowenwik; Carl-Olof Sjöberg; Ewa Selg
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-10-15       Impact factor: 2.849

8.  Exposure to ultrafine carbon particles at levels below detectable pulmonary inflammation affects cardiovascular performance in spontaneously hypertensive rats.

Authors:  Swapna Upadhyay; Tobias Stoeger; Volkar Harder; Ronald F Thomas; Mette C Schladweiler; Manuela Semmler-Behnke; Shinji Takenaka; Erwin Karg; Peter Reitmeir; Michael Bader; Andreas Stampfl; Urmila P Kodavanti; Holger Schulz
Journal:  Part Fibre Toxicol       Date:  2008-12-04       Impact factor: 9.400

9.  On the pivotal role of dose for particle toxicology and risk assessment: exposure is a poor surrogate for delivered dose.

Authors:  Otmar Schmid; Flemming R Cassee
Journal:  Part Fibre Toxicol       Date:  2017-12-08       Impact factor: 9.400

10.  Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption.

Authors:  Johanna Eriksson; Erik Sjögren; Hans Lennernäs; Helena Thörn
Journal:  AAPS J       Date:  2020-05-11       Impact factor: 4.009

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.